But semaglutide developer Novo Nordisk announced late last year that, after 2 years on the drug, patients showed no memory improvement
The growing popularity of GLP-1 treatments has influenced everything from local healthcare supply chains to dining culture, with some Dubai restaurants now offering smaller portion menus to cater to those using appetite-suppressing drugs
Notably, with a significant 29% risk reduction when looking at three or more years exposure to GLP-1RA. They added, Our sensitivity analysis supported the finding of risk reduction when looking at users of GLP-1RA. These findings support the possibility of GLP-1RA being an adjunctive therapy to IOP-reducing eye drops in glaucoma management, the authors argue
AOD9604 is not FDAapproved for any medical indication, and FDA advisory documents note concerns about immunogenicity, peptide-related impurities, and lack of sufficient safety and efficacy data
Related: NCSLs Prescription Drug Policy Resource Center States offer prescription drug benefits through both state employee health plans and Medicaid, but coverage for GLP-1 medications varies
97 Early findings also suggest potential protection against Alzheimers-related cognitive decline and co-morbidities 98
